Skip to main content
Clinical Trials/NL-OMON39635
NL-OMON39635
Completed
Phase 3

Prospective randomized trial to evaluate and to compare the impact of hysteroscopic Essure® intratubal device placement and laparoscopic salpingectomy on IVF-ET outcomes of patients with hydrosalpinx. - The DESH (Dutch Essure® versus Salpingectomy for Hydrosalpinx) Trial.

Vrije Universiteit Medisch Centrum0 sites80 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Blocked fallopian tube filled with fluid
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
80
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Presence of uni\- or bilateral hydrosalpinges (established with transvaginal ultrasouns)
  • \- Female age \<\= 40 years at the time of randomization
  • \- Patient suitable for IVF\-ET treatment
  • \- Patient suitable for laparoscopic surgery

Exclusion Criteria

  • \- Female age \> 40 years at the time of randomization
  • \- Pregnancy or suspected pregnancy
  • \- Recent or active pelvic infection
  • \- Evidence of proximal tubal occlusion in the hydrosalpinx seen at HSG or at laparoscopy
  • \- Patient not suitable for IVF\-ET
  • \- Patient not suitable for laparoscopic surgery

Outcomes

Primary Outcomes

Not specified

Similar Trials